Herpes Simplex Completed Phase 3 Trials for Acyclovir (DB00787)

Also known as: Herpesviral infection, unspecified / Herpes simplex (disorder) / HSV infection / Herpesviral [herpes simplex] infections / Herpes simplex NOS

IndicationStatusPhase
DBCOND0027882 (Herpes Simplex)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00031447
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and MouthTreatment
NCT00855309
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With NeutropeniaSupportive Care
NCT00000985
Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With AcyclovirTreatment
NCT00006135
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and MouthTreatment
NCT00000139
Herpetic Eye Disease Study (HEDS) IITreatment
NCT00004757
Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthTreatment
NCT00031460
Acyclovir for Herpes Infections Involving the Central Nervous System in NeonatesTreatment